Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05407675
Title A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | CHE | CAN

Facility Status City State Zip Country Details
Local Institution - 0010 Boston Massachusetts 02215 United States Details
Local Institution - 0001 Hackensack New Jersey 07601 United States Details
Local Institution - 0003 Houston Texas 77030 United States Details
Local Institution - 0007 Edmonton Alberta T6G 1Z2 Canada Details
Local Institution - 0011 Hamilton Ontario L8V5C2 Canada Details
Local Institution - 0005 Ottawa Ontario K1H 8L6 Canada Details
Local Institution - 0006 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 0015 Bordeaux Aquitaine 33076 France Details
Local Institution - 0014 Villejuif Paris 94800 France Details
Local Institution - 0018 Marseille 13385 France Details
Local Institution - 0019 Toulouse 31059 France Details
Local Institution - 0024 Málaga Andalucía 29010 Spain Details
Local Institution - 0025 Madrid Madrid, Comunidad De 28009 Spain Details
Local Institution - 0022 Madrid 28040 Spain Details
Local Institution - 0023 Madrid 28050 Spain Details
Local Institution - 0021 st.Gallen Sankt Gallen 9007 Switzerland Details
Local Institution - 0012 Basel 4031 Switzerland Details
Local Institution - 0020 Genève 1211 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field